NNMX — Nanomix Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $11.46m
- $0.02m
Annual balance sheet for Nanomix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.012 | 0.007 | 0.007 | 0.297 | 0.017 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | — | — | 0 | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.922 | 0.023 | 0.02 | 0.469 | 0.08 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.002 | 0.001 | 0 | 0.339 | 0.833 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1.44 | 0.024 | 0.02 | 0.906 | 0.982 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.66 | 7.7 | 8.6 | 3.33 | 4.05 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.59 | 7.7 | 8.6 | 6.94 | 14.2 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -4.15 | -7.67 | -8.58 | -6.04 | -13.2 |
Total Liabilities & Shareholders' Equity | 1.44 | 0.024 | 0.02 | 0.906 | 0.982 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |